Robert Haddad
Dana-Farber Cancer Institute

Last Updated On 3/31/2024 4:39:17 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: Dana-Farber Cancer Institute
Recipient: You

Leadership
Company: NCCN
Recipient: You

Stock and Other Ownership Interests
Company: tosk
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Merck
Recipient: You
Company: Eisai
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You
Company: AstraZeneca
Recipient: You
Company: GSK
Recipient: You
Company: EMD Serono
Recipient: You
Company: Bayer
Recipient: You
Company: Coherus Biosciences
Recipient: You
Company: Boehringer Ingelheim
Recipient: You
Company: Genmab
Recipient: You
Company: Galera Therapeutics
Recipient: You
Company: Merus
Recipient: You
Company: ALX Oncology
Recipient: You
Company: PDS Biotechnology
Recipient: You
Company: Scholar Rock
Recipient: You
Company: aveo
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Merck
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution
Company: Genentech
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution
Company: Kura
Recipient: Your Institution
Company: EMD Serono
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: up to Date
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
Company: Nanobiotix
Recipient: You
Company: ISA Pharmaceuticals
Recipient: You
Company: Boehringer Ingelheim
Recipient: You
Company: Hookipa Pharma
Recipient: You

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered